论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Liu Y, Meng Y, Wang L, Liu Z, Li J, Dong W
Received 12 June 2018
Accepted for publication 8 October 2018
Published 23 November 2018 Volume 2018:11 Pages 8309—8317
DOI https://doi.org/10.2147/OTT.S177007
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr William Cho
Background and aim: Despite
several studies being conducted to examine the associations between the NUDT15 R139C
polymorphism and thiopurine-induced leukopenia in the Asian population, the
results remain inconsistent. This meta-analysis determined the risk of
thiopurine-induced leukopenia conferred by the NUDT15 R139C
polymorphism.
Materials and methods: All
eligible studies published in English up to May 2018 were identified by
searching PubMed, Web of Science, Embase, and the Cochrane Library. Pooled OR
and 95% CI were calculated using fixed- or random-effect model.
Results: In all,
total of 14 studies containing 918 patients and 2,341 controls were included;
of these, 8 studies concerned inflammatory bowel disease (IBD) and 4 concerned acute
lymphoblastic leukemia (ALL). Overall, the results indicated that the NUDT15 R139C
polymorphism was associated with leukopenia induced by thiopurines (OR =9.04,
95% CI 6.05–13.50, P <0.001 for the dominant model; OR =24.26, 95% CI
11.38–51.71, P <0.001 for the recessive model; OR =7.60, 95% CI
4.97–11.61, P <0.001 for the CT vs TT model; OR =38.47, 95% CI
17.78–83.24, P <0.001 for the CC vs TT model). In subgroup
analyses, significant associations were found among patients with IBD (OR
=7.57, 95% CI 5.16–11.12, P <0.001 for the dominant model), ALL (OR =13.13,
95% CI 3.43–50.23 P <0.001 for the dominant model), and other diseases
(OR =31.22, 95% CI 1.20–814.07, P =0.04 for the dominant model). In addition, the R139C
variant was strongly associated with early (<8 weeks) (OR =15.53, 95% CI
7.91–30.50, P <0.001 for the dominant model) and late leukopenia
(≥8 weeks) (OR =2.92, 95% CI 2.01–4.24, P <0.001 for the dominant model). Moreover, these
findings were sufficiently robust when studies without Hardy–Weinberg equilibrium
test were excluded.
Conclusion: This
meta-analysis verified the strong association between the NUDT15 R139C
polymorphism and thiopurine-induced leukopenia (both early and late leukopenia)
in an Asian population with IBD, ALL, and other diseases. NUDT15 R139C
genotyping should be prioritized to predict leukopenia among Asians.
Keywords: NUDT15 R139C,
leukopenia, thiopurine, polymorphism, IBD, ALL, meta-analysis
